Agilent Technologies Inc. has named Roeland G.W. Verhaak, of the Jackson Laboratory (JAX), the winner of the company’s Early Career Professor Award. Verhaak was selected for his contributions to the implementation of transcriptomics, genomics, and big-data analysis to the classification and diagnosis of various cancer types.
Agilent Technologies Inc. has named Roeland G.W. Verhaak, of the Jackson Laboratory (JAX), the winner of the company’s Early Career Professor Award. Verhaak was selected for his contributions to the implementation of transcriptomics, genomics, and big-data analysis to the classification and diagnosis of various cancer types.
“Agilent is pleased to recognize Dr. Verhaak with this award and to support his important research at JAX,” said Jack Wenstrand, Agilent’s director of university relations and external research.
“Dr. Verhaak is recognized internationally for the development and implementation of workflows for the analysis of big-data from transcriptomics to next generation sequencing approaches. His data-driven, unbiased analyses of cancer genomics and profound understanding of cancer biology are improving our ability to identify clinically relevant subtypes of cancer,” continued Wenstrand.
Established in 2008, the Agilent Early Career Professor Award seeks to recognize the achievements of academic researchers in the early stages of their careers and to establish strong collaborative relationships.
“We’re so pleased that Dr. Verhaak has received this prestigious award in recognition of his outstanding work in advancing human health,” said Charles Lee, Ph.D., FACMG, scientific director and professor at JAX Genomic Medicine.
For more information, please visit: www.agilent.com/about/newsroom/presrel/2016/18oct-ca16031.html
Simultaneous Screening of Pesticide Residues in Date Fruits with UHPLC–MS/MS and GC–MS/MS
March 7th 2025Comprehensive information was derived through the utilization of a QuEChERS-UHPLC–MS/MS and GC–MS/MS method for the detection of 211 volatile and stable pesticide residues in 90 date fruit samples.
The Next Frontier for Mass Spectrometry: Maximizing Ion Utilization
January 20th 2025In this podcast, Daniel DeBord, CTO of MOBILion Systems, describes a new high resolution mass spectrometry approach that promises to increase speed and sensitivity in omics applications. MOBILion recently introduced the PAMAF mode of operation, which stands for parallel accumulation with mobility aligned fragmentation. It substantially increases the fraction of ions used for mass spectrometry analysis by replacing the functionality of the quadrupole with high resolution ion mobility. Listen to learn more about this exciting new development.
Pick Your Poison. Isolation of Paclitaxel (Mar 2025)
March 7th 2025The diterpenoid, paclitaxel, which was identified as a potent chemotherapy agent for breast and ovarian cancer originates from the Pacific Yew tree. The isolation of paclitaxel from its major impurities is shown with the use of Hamilton’s PRP-1 (5 µm) HPLC column.